These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
413 related articles for article (PubMed ID: 29020172)
21. Prevalence of cryptococcal infection among advanced HIV patients in Argentina using lateral flow immunoassay. Frola C; Guelfand L; Blugerman G; Szyld E; Kaufman S; Cahn P; Sued O; Pérez H PLoS One; 2017; 12(6):e0178721. PubMed ID: 28617817 [TBL] [Abstract][Full Text] [Related]
22. Outcomes of Reflex Cryptococcal Antigen (CrAg) Screening in Human Immunodeficiency Virus (HIV)-Positive Patients With CD4 Counts of 100-200 Cells/µL in Botswana. Tenforde MW; Milton T; Rulaganyang I; Muthoga C; Tawe L; Chiller T; Greene G; Jordan A; Williams CG; Owen L; Leeme TB; Boose A; Ngidi J; Mine M; Jarvis JN Clin Infect Dis; 2021 May; 72(9):1635-1638. PubMed ID: 32604411 [TBL] [Abstract][Full Text] [Related]
23. Prevalence, correlates, and outcomes of cryptococcal antigen positivity among patients with AIDS, United States, 1986-2012. McKenney J; Bauman S; Neary B; Detels R; French A; Margolick J; Doherty B; Klausner JD Clin Infect Dis; 2015 Mar; 60(6):959-65. PubMed ID: 25422390 [TBL] [Abstract][Full Text] [Related]
24. The prevalence of cryptococcal antigen (CrAg) and benefits of pre-emptive antifungal treatment among HIV-infected persons with CD4+ T-cell counts < 200 cells/μL: evidence based on a meta-analysis. Li Y; Huang X; Chen H; Qin Y; Hou J; Li A; Wu H; Yan X; Chen Y BMC Infect Dis; 2020 Jun; 20(1):410. PubMed ID: 32532212 [TBL] [Abstract][Full Text] [Related]
25. Combination flucytosine and high-dose fluconazole compared with fluconazole monotherapy for the treatment of cryptococcal meningitis: a randomized trial in Malawi. Nussbaum JC; Jackson A; Namarika D; Phulusa J; Kenala J; Kanyemba C; Jarvis JN; Jaffar S; Hosseinipour MC; Kamwendo D; van der Horst CM; Harrison TS Clin Infect Dis; 2010 Feb; 50(3):338-44. PubMed ID: 20038244 [TBL] [Abstract][Full Text] [Related]
26. Serum cryptococcal antigen titre as a diagnostic tool and a predictor of mortality in HIV-infected patients with cryptococcal meningitis. Chen J; Zhang R; Shen Y; Liu L; Qi T; Wang Z; Mehraj V; Routy JP; Lu H HIV Med; 2019 Jan; 20(1):69-73. PubMed ID: 30311440 [TBL] [Abstract][Full Text] [Related]
27. Point-of-Care Testing for Cryptococcal Disease Among Hospitalized Human Immunodeficiency Virus-Infected Adults in Ethiopia. Mamuye AT; Bornstein E; Temesgen O; Blumberg HM; Kempker RR Am J Trop Med Hyg; 2016 Oct; 95(4):786-792. PubMed ID: 27527636 [TBL] [Abstract][Full Text] [Related]
29. Six-month outcomes of HIV-infected patients given short-course fluconazole therapy for asymptomatic cryptococcal antigenemia. Kapoor SW; Magambo KA; Kalluvya SE; Fitzgerald DW; Peck RN; Downs JA AIDS; 2015 Nov; 29(18):2473-8. PubMed ID: 26372487 [TBL] [Abstract][Full Text] [Related]
30. Preventing deaths from cryptococcal meningitis: from bench to bedside. Roy M; Chiller T Expert Rev Anti Infect Ther; 2011 Sep; 9(9):715-7. PubMed ID: 21905781 [TBL] [Abstract][Full Text] [Related]
31. A qualitative evaluation of an implementation study for cryptococcal antigen screening and treatment in Uganda. Lofgren SM; Nalintya E; Meya DB; Boulware DR; Rajasingham R Medicine (Baltimore); 2018 Aug; 97(31):e11722. PubMed ID: 30075580 [TBL] [Abstract][Full Text] [Related]
32. Cost-effectiveness of single-dose AmBisome pre-emptive treatment for the prevention of cryptococcal meningitis in African low and middle-income countries. Rajasingham R; Nalintya E; Israelski DM; Meya DB; Larson BA; Boulware DR Med Mycol; 2022 Feb; 60(2):. PubMed ID: 35026017 [TBL] [Abstract][Full Text] [Related]
33. Treatment of experimental cryptococcal meningitis with fluconazole: impact of dose and addition of flucytosine on mycologic and pathophysiologic outcome. Kartalija M; Kaye K; Tureen JH; Liu Q; Täuber MG; Elliott BR; Sande MA J Infect Dis; 1996 May; 173(5):1216-21. PubMed ID: 8627075 [TBL] [Abstract][Full Text] [Related]
34. LATERAL FLOW ASSAY FOR CRYPTOCOCCAL ANTIGEN: AN IMPORTANT ADVANCE TO IMPROVE THE CONTINUUM OF HIV CARE AND REDUCE CRYPTOCOCCAL MENINGITIS-RELATED MORTALITY. Vidal JE; Boulware DR Rev Inst Med Trop Sao Paulo; 2015 Sep; 57 Suppl 19(Suppl 19):38-45. PubMed ID: 26465368 [TBL] [Abstract][Full Text] [Related]